Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc > Quiet Board and Silent Management
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Hideawayon Aug 24, 2020 12:33pm
139 Views
Post# 31446074

RE:RE:Quiet Board and Silent Management

RE:RE:Quiet Board and Silent Management Agree that we may not see a lot of price action with the start announcement but later start dates also will delay results from phase 1. If results meet expectations then we should see a nice reaction.
The dismal stock price today does not bode well for the future and delaying the publication of the animal trials is not helping.What the h... is wrong with management.Get the lead out.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities